Study of Irinotecan,Oxaliplatin, and S1 in Patients With Advanced Pancreatic Cancer
Clinical trial NCT03726021 · COMPLETED
Trial details
- NCT number
- NCT03726021
- Sponsor
- Qingdao Central Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-26
- Primary completion
- 2022-12-31
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.